Skip to main content

Low rate of adverse events recorded in English primary care

A study by Dr Carmen Tsang and colleagues at Imperial College London has found a low incidence of patient safety incidents recorded in general practice. The research, which was published by the British Journal of General Practice, measured the extent of patient safety incidents recorded in 74 763 patients at 457 English general practices between 1999 and 2008, and the patient characteristics associated with these adverse events.

Older patients, those with more comorbid diseases or who had more previous emergency admissions to hospital were at greater risk of complications of care. Dr Carmen Tsang, lead author of the paper, says “Our finding of a low incidence of patient harm in general practice supports previously published studies. To better understand these adverse events, we must also examine the healthcare interactions from which they originate, and consider how to reduce the incidents that are potentially preventable”.

Outcomes following adverse events, including emergency admissions and death, are important because they may be preventable. The low rate of recording of adverse events in primary care may reflect under-recording of safety incidents occurring in this setting. Routine recording of adverse events, may be less frequent and less precise than recording of chronic diseases. The reasons for the low rate of adverse events detected needs to be better understood, particularly if this rate is an under-estimation of the true extent of iatrogenic patient harm in primary care.

Comments

Popular posts from this blog

The Hidden Cost of Cheaper NHS Contracts: Losing Community Trust

NHS budgets are under considerable pressure. It is therefore unsurprising that many NHS Integrated Care Boards (ICBs) In England will aim to prioritise price in contract awards, But this approach is a significant threat to community-centred healthcare. While competitive tendering is a legally required, an excessive focus on costs in awarding NHS contracts risks overshadowing key factors such as established community trust, local expertise, and the long-term impact on continuity of care. This shift towards cheaper, often external, commercial providers threatens to cut the links between communities and their local health services. The argument that competitive tendering is solely about legal compliance, and not cost, is undermined by the very nature of such tendering, which by design encourages the lowest bid. This approach risks eroding the social fabric of local healthcare provision, where established relationships and understanding of specific community needs are essential. Establishe...

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...